Labeled for this condition
Medicines for blood clots (dvt and pe)
12 medicines have an FDA label indicated for blood clots (DVT and PE); 8 are listed from generic labelers and 1 has a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for blood clots (dvt and pe)?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Enoxaparin | Lovenox | 16 labelers | $6.45 per mL 100 mg/mL syringe | Yes | No current entry | 6 |
| Warfarin | Jantoven | 19 labelers | $0.093 per tablet 2 mg tablet | Yes | No current entry | 7 |
| Heparin | none listed | 18 labelers | $1.18 per mL 5,000 unit/mL vial | No | In shortage | 18 |
| Dabigatran | Pradaxa | 16 labelers | $0.795 per capsule 150 mg capsule | Yes | No current entry | 9 |
| Rivaroxaban | Xarelto | 20 labelers | $0.650 per tablet 2.5 mg tablet | Yes | A presentation being discontinued | 1 |
| Fondaparinux | Arixtra | 5 labelers | $44.82 per mL 10 mg/0.8 mL syringe | Yes | No current entry | 1 |
| Apixaban | Eliquis | 2 labelers | $5.52 per tablet 5 mg tablet | Yes | No current entry | 0 |
| Dalteparin | Fragmin | none listed | n/a | Yes | No current entry | 0 |
| Alteplase | Activase, Cathflo | none listed | $186.38 per vial 2 mg vial | No | A presentation being discontinued | 2 |
| Dextrose and heparin | none listed | none listed | n/a | No | No current entry | 3 |
| Edoxaban | Savaysa | none listed | $15.51 per tablet 60 mg tablet | Yes | No current entry | 0 |
| Dextran 40 | Lmd | 1 labeler | n/a | No | No current entry | 1 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price